PA-19-054 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 19
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest: NCCIH High Priority Pain Research | NOT-AT-22-007 | NCCIH | Dec 20, 2021 | Dec 15, 2022 | R01, R21, R15, R34 |
Notice of Special Interest (NOSI): Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults | NOT-DA-20-014 | NIDA | Apr 22, 2020 | Sep 8, 2023 | R01, R03, R21 |
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions | NOT-CA-20-044 | NCI | Apr 9, 2020 | May 8, 2023 | R03, R21, R01, P01 |
Notice of Special Interest (NOSI):Sleep and Substance Use Disorders | NOT-DA-20-021 | NIDA | Mar 25, 2020 | Sep 8, 2023 | R01, R03, R21, K99/R00, R61/R33 |
Notice of Special Interest (NOSI): Competitive Revisions for Firearms Injury and Mortality Prevention Research | NOT-OD-20-089 | OBSSR NIA NICHD NIMH NCCIH ODP NIMHD ORWH NIAAA | Mar 20, 2020 | May 16, 2020 | R01, R21 |
Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD) | NOT-CA-20-031 | NCI NIDCR | Mar 10, 2020 | Jan 8, 2022 | R03, R21, R01 |
Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain | NOT-DA-20-039 | NIDA | Mar 5, 2020 | Sep 8, 2023 | R01, R03, R21 |
Notice of Special Interest (NOSI): Mechanistic Investigations of Psychosocial Factors Associated with Substance Use Disorders | NOT-DA-20-005 | NIDA | Mar 3, 2020 | Sep 8, 2023 | R01, R21 |
Notice of Special Interest (NOSI): Drug-drug interactions among substances of abuse, medications to treat HIV infection, and pharmacotherapies to treat substance use disorders | NOT-DA-20-013 | NIDA | Feb 6, 2020 | May 8, 2022 | R01, R03, R21 |
Notice of Special Interest (NOSI): Preclinical and Clinical Studies of the Interactions of Opioids and Stimulants | NOT-DA-20-007 | NIDA | Jan 6, 2020 | Jun 5, 2023 | R03, R21, R01 |
Notice of Special Interest (NOSI): Modeling Social Contagion of Substance Use Epidemics | NOT-DA-20-009 | NIDA | Jan 2, 2020 | Jan 8, 2023 | R01, R03, R21 |
Notice of Special Interest: Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes | NOT-AT-20-002 | NCCIH | Dec 13, 2019 | Jan 8, 2022 | R01, R21 |
Notice of Special Interest (NOSI): Epidemiology of Drug Abuse | NOT-DA-19-066 | NIDA | Aug 29, 2019 | Jan 8, 2022 | R01, R21, R03, 333 |
Notice of Special Interest (NOSI): Public Health Research on Cannabis | NOT-DA-19-065 | NIDA | Aug 14, 2019 | Jan 8, 2022 | R01, R21, R03, 333 |
Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research | NOT-DA-19-041 | NIDA | Jul 12, 2019 | Jan 8, 2022 | R01, R21, R03 |
Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R01, R21, R03) | NOT-DA-19-037 | NIDA | Jul 11, 2019 | Sep 8, 2022 | R01, R21, R03 |
Notice of Special Interest (NOSI): Research to Prevent Drug Use, Misuse and Addiction | NOT-DA-19-048 | NIDA | Jul 10, 2019 | Jan 8, 2022 | R01, R21, R03 |
Notice of Special Interest (NOSI): Gene-Environment Interplay in Substance Use Disorders (R01, R21) | NOT-DA-19-038 | NIDA | Jul 10, 2019 | Jan 8, 2022 | R01, R21 |
Notice of Availability of Competitive Supplements/Revisions for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Competitive Supplement/Revision Clinical Trial Optional) | NOT-OD-19-071 | NIH | Feb 5, 2019 | Mar 17, 2019 | R01, R03, R21, U01 |